Registry of restriction intentions until outcome
Registry of restriction intentions until outcome
Registry of restriction intentions until outcome
The registry of restriction intentions until outcome lists the intentions and Annex XV restriction proposals received by ECHA.
A restriction proposal may be prepared by a Member State or by ECHA at the request of the Commission or on its own initiative for substances in the Authorisation List. It is a legal requirement for a Member State to notify ECHA of its intention to prepare a restriction dossier. The advance notice enables interested parties to plan and prepare for commenting later on.
Interested parties can follow the progress of a proposal through the restriction process, from the notification of the intention to the adoption of the final opinions by the Committee for Risk Assessment (RAC) and the Committee for Socio-economic Analysis (SEAC), and the adoption of the restriction by the European Commission.
Stakeholders are encouraged to submit any relevant information to the dossier submitters during the preparation of the restriction proposal and during the consultations. Information to motivate any exemptions to the scope described in the intention is particularly useful to receive in the preparatory phase of the dossier.
1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”™)
covering any of its individual anti- and syn-isomers or any combination thereof EC / List no: - CAS no: -CLP Annex VI Index number | |
Further substance information | Non-exhaustive list of relevant numerical identifiers for the Candidate List entry “1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene (“Dechlorane Plus”TM) [covering any of its individual antiand syn- isomers or any combination thereof]”, see: https://echa.europa.eu/documents/10162/9aa77dde-f0fc-4422-2c00-55b620e57552 |
Submitter(s) | Norway |
Details on the scope of restriction | The proposal intends to restrict the manufacture, use and placing on the market of Dechlorane Plus™ as substances, constituents of other substances, mixtures and articles. |
Reason for restriction | Dechlorane Plus is a substance of very high concern due to its very persistent and very bioaccumulating properties. The substance is widely detected in the global environment and some studies indicate increasing concentrations. Dechlorane plus has also been detected in human blood, placenta and breast milk. Norway has submitted a proposal to list Dechlorane Plus and its syn- and anti-isomers in Annexes A, B and/or C to the Stockholm Convention on Persistent Organic Pollutants. |
Remarks | |
Status | Opinions adopted |
Date of intention | 26-aug.-2020 |
Expected date of submission | 09-ápr.-2021 |
Withdrawal date | |
Reason for withdrawal | |
Start of Call for Evidence consultation | 01-ápr.-2020 |
Deadline for comments on the Call for Evidence | 15-jún.-2020 |
Start of second Call for Evidence consultation | |
Deadline for comments on the second Call for Evidence | |
Start of third Call for Evidence consultation | |
Deadline for comments on the third Call for Evidence | |
Restriction report (and annexes) | |
Information note on restriction report | |
Start of Annex XV report consultation | 23-jún.-2021 |
1st deadline for comments on Annex XV report | 28-júl.-2021 |
Final deadline for comments on Annex XV report | 03-jan.-2022 |
Comments on Annex XV report | |
Opinion of RAC (and minority positions) and Forum Enforceability Advice (as of September 2023) | |
Draft opinion of SEAC | |
RAC & SEAC (draft) Background document (and annexes) | |
Start of SEAC draft opinion consultation | 17-márc.-2022 |
Deadline for comments on SEAC draft opinion | 16-máj.-2022 |
Comments on SEAC draft opinion | |
Compiled RAC and SEAC opinion (and minority positions) | |
Final background document (and annexes) | |
Adopted restriction/Commission communication | |
Latest update | 12-szept.-2022 |
First published | 02-szept.-2020 |
![Help Help](https://chesar.echa.europa.eu/o/echa-revamp-theme/images/gui/help.png)
Name | EC / List no. | CAS no. | Association |
---|---|---|---|
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene | - | 135821-03-3 | Official source |
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene | - | 135821-74-8 | Official source |
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene | 236-948-9 | 13560-89-9 | Official source |
rel-(1R,4S,4aS,6aS,7S,10R,10aR,12aR)-1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro-1,4:7,10-dimethanodibenzo[a,e]cyclooctene | - | - | Expert judgement (ECHA) |
rel-(1R,4S,4aS,6aR,7R,10S,10aS,12aR)-1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro-1,4:7,10-dimethanodibenzo[a,e]cyclooctene | - | - | Expert judgement (ECHA) |